
Statistical Methods for Immunogenicity Assessment
729,-

Design and Analysis of Clinical Trials With Time-to-Event Endpoints
2 129,-

Adaptive Design Methods in Clinical Trials
2 129,-

Biosimilar Clinical Development
729,-

Statistical Methods in Drug Combination Studies
729,-

Randomized Phase II Cancer Clinical Trials
1 349,-

Applied Surrogate Endpoint Evaluation Methods With SAS and R
729,-

Repeated Measures Design with Generalized Linear Mixed Models for Randomized Controlled Trials
729,-

Bioequivalence and Statistics in Clinical Pharmacology
729,-

Measures of Interobserver Agreement and Reliability
729,-

Statistical Methods for Immunogenicity Assessment
729,-

Design and Analysis of Clinical Trials With Time-to-Event Endpoints
2 129,-

Adaptive Design Methods in Clinical Trials
2 129,-

Biosimilar Clinical Development
729,-

Statistical Methods in Drug Combination Studies
729,-

Randomized Phase II Cancer Clinical Trials
1 349,-

Applied Surrogate Endpoint Evaluation Methods With SAS and R
729,-

Repeated Measures Design with Generalized Linear Mixed Models for Randomized Controlled Trials
729,-

Bioequivalence and Statistics in Clinical Pharmacology
729,-

Measures of Interobserver Agreement and Reliability
729,-